Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy

References

• Hellman S, Weichselbaum R. Oligometastases. J Clin Oncol. 1995;13(1):8–10.
   PubMed Web of Science ®Google Scholar
• Barney J, Churchill E. Adenocarcinoma of the kidney with metastasis to the lung cured by nephrectomy and lobectomy. J Urol. 1939;42(3):269–276.
   Google Scholar
• Rosenberg SA. Surgical treatment of metastatic cancer. Philadelphia (PA): Lippincott Williams & Wilkins; 1987.
   Google Scholar
• Peters LJ, Milas L, Fletcher GH. The role of radiation therapy in the curative treatment of metastatic disease. Symp Fundam Cancer Res. 1983;36:411–420.
   Google Scholar
• Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (sabr-comet): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051–2058.
   PubMed Web of Science ®Google Scholar
• Gomez DR, Tang C, Zhang J, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019;37(18):1558–1565.
   PubMed Web of Science ®Google Scholar
• Ost P, Reynders D, Decaestecker K, et al. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. 2018;36(5):446–453.
   PubMed Web of Science ®Google Scholar
• Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol. 2018;4(1):e173501.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Lievens Y, Bouma AB, et al. Characterisation and classification of oligometastatic disease: a European Society for radiotherapy and oncology and European Organisation for research and treatment of cancer consensus recommendation. Lancet Oncol. 2020;21(1):e18–e28.
   PubMed Web of Science ®Google Scholar
• Lussier YA, Khodarev NN, Regan K, et al. Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One. 2012;7(12):e50141.
   PubMed Web of Science ®Google Scholar
• Lussier YA, Xing HR, Salama JK, et al. MicroRNAs expression characterizes oligometastasis(es). PLoS One. 2011;6(12):e28650.
   PubMed Web of Science ®Google Scholar
• Wong AC, Watson SP, Pitroda SP, et al. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT). Cancer. 2016;122(14):2242–2250.
   PubMed Web of Science ®Google Scholar
• Pitroda SP, Khodarev NN, Huang L, et al. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018;9(1):1793.
   PubMed Web of Science ®Google Scholar
• Hong JC, Ayala-Peacock DN, Lee J, et al. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis. PLoS One. 2018;13(4):e0195149.
   PubMed Web of Science ®Google Scholar
• Van den Begin R, Benedikt Engels B, Christine Collen C, et al. The METABANK score: a clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease. Radiother Oncol. 2019;133:113–119.
   PubMed Web of Science ®Google Scholar
• Franceschini D, De Rose F, Franzese C, et al. Predictive factors for response and survival in a cohort of oligometastatic patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2019;104(1):111–121.
   PubMed Web of Science ®Google Scholar
• Therneau TM. A package for survival analysis in S. version 2.38. 2015. https://CRAN.R-project.org/package=survival) of the R software (R Core Team 2020). R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing. https://www.R-project.org/
   Google Scholar
• Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27(11):1806–1813.
   PubMed Web of Science ®Google Scholar